newsfilter
← Latest News
GlobeNewswire·

Imara Reports Third Quarter 2020 Financial Results and Business Highlights

Patient Dosing Underway in Phase 2b clinical trials of IMR-687 in sickle cell disease and beta-thalassemia IMR-687 granted Orphan Drug designation from European Commission for sickle cell disease ...